Sudarshan Pharma Industries Limited Stock

Equities

SUDARSHAN

INE00TV01015

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:53 2024-04-26 am EDT 5-day change 1st Jan Change
78 INR +1.71% Intraday chart for Sudarshan Pharma Industries Limited -2.63% -4.05%
Sales 2022 3.57B 42.86M Sales 2023 4.61B 55.33M Capitalization 960M 11.51M
Net income 2022 53M 636K Net income 2023 70M 840K EV / Sales 2022 * -
Net Debt 2022 304M 3.64M Net Debt 2023 224M 2.68M EV / Sales 2023 0.26 x
P/E ratio 2022 *
-
P/E ratio 2023
19.1 x
Employees 56
Yield 2022 *
-
Yield 2023
0.54%
Free-Float 30.73%
More Fundamentals * Assessed data
Dynamic Chart
Sudarshan Pharma Industries Limited Announces Resignation of Ishita Samani as Company Secretary and Compliance Officer CI
1,165,368 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 30-MAR-2024. CI
11,224,937 Equity Shares of Sudarshan Pharma Industries Limited are subject to a Lock-Up Agreement Ending on 29-MAR-2024. CI
Sudarshan Pharma Industries Limited Appoints Sachin Mehta as the Chief Financial Officer, Effective December 12, 2023 CI
Sudarshan Pharma Industries Limited Announces Resignation of Nilesh Thakkar as Additional Director CI
Sudarshan Pharma Industries Limited Announces Board Changes CI
Sudarshan Pharma Industries Limited Announces Resignation of Mr. Dharam Jilka from the Position of Chief Financial Officer with Effect from September 15, 2023 CI
Sudarshan Industries Limited Announces Intimation for Incorporation of A Subsidiary Company CI
Sudarshan Pharma Industries Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Sudarshan Pharma Industries Limited signed a definitive agreement to acquire Ratna Lifesciences Pvt Ltd for INR 55 million. CI
Sudarshan Pharma Industries to Consider Acquisition of Ratna Lifesciences as Unit CI
Sudarshan Pharma Industries Limited Recommends Dividend for the Financial Year 2022-23, Payable on and from September 05, 2023 CI
Sudarshan Pharma Industries Limited Appoints Mr. Rushabh P Patil as Additional Director CI
Sudarshan Pharma Industries Limited Announces Resignation of RAJESH CHANDRAKUMAR HEDAOO as Director CI
Sudarshan Pharma Industries Limited has completed an IPO in the amount of INR 501.072 million. CI
More news
1 day+1.71%
1 week-2.63%
Current month+5.25%
1 month+5.41%
3 months+3.39%
6 months+3.31%
Current year-4.05%
More quotes
1 week
74.00
Extreme 74
80.75
1 month
70.30
Extreme 70.3
81.99
Current year
65.00
Extreme 65
85.99
1 year
62.00
Extreme 62
91.90
3 years
51.85
Extreme 51.85
91.90
5 years
51.85
Extreme 51.85
91.90
10 years
51.85
Extreme 51.85
91.90
More quotes
Managers TitleAgeSince
Chief Executive Officer 38 08-07-22
Chief Executive Officer 46 15-01-15
Comptroller/Controller/Auditor - -
Members of the board TitleAgeSince
Chief Executive Officer 46 15-01-15
Chief Executive Officer 38 08-07-22
Director/Board Member 30 23-07-20
More insiders
Date Price Change Volume
24-04-26 78 +1.71% 152,000
24-04-25 76.69 -0.51% 73,600
24-04-24 77.08 -2.84% 16,000
24-04-23 79.33 +0.42% 46,400
24-04-22 79 -1.39% 11,200

Delayed Quote Bombay S.E., April 26, 2024 at 06:00 am EDT

More quotes
Sudarshan Pharma Industries Limited is an India-based company, which is engaged in job work manufacturing in pharmaceutical items and traders in chemicals and solvents in India. The Company operates in the State of Maharashtra, Gujarat, Himachal Pradesh, and Uttarakhand. The Company is involved in specialty chemicals and intermediates for pharma, agriculture chemicals, coating, paints, adhesive, and various other industries. It is also into active pharmaceuticals ingredients manufacturing. It is also into specialty chemicals imports and exports, as well as supply of same to the actual users. The Company provides customize specialty chemicals to its clients in India and abroad regularly. The Company is also involved in contract manufacturing, outsource and supply of generic pharma formulation, and medicines to healthcare institution, government, non-governmental organization (NGO) and hospitals.
More about the company
  1. Stock Market
  2. Equities
  3. SUDARSHAN Stock